Honghao Zhang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Targeting CARM1 impairs DNA damage repair and attenuates B-cell acute lymphoblastic leukemia progression.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 17, 2025
Chimeric Antigen Receptor T-Cell Therapy-Associated Infections in Hematologic Malignancies: A Real-World Pharmacovigilance Analysis.
Journal: Transplantation and cellular therapy
Published: November 03, 2025
A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy.
Journal: Human vaccines & immunotherapeutics
Published: June 17, 2025
Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity.
Journal: International journal of biological macromolecules
Published: December 22, 2024
Inhibition of VEGF signaling prevents exhaustion and enhances anti-leukemia efficacy of CAR-T cells via Wnt/β-catenin pathway.
Journal: Journal of translational medicine
Published: July 08, 2024
Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.
Journal: Cancer gene therapy
Published: April 14, 2024
High-throughput screening for optimizing adoptive T cell therapies.
Journal: Experimental hematology & oncology
Published: March 20, 2024
Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in Chronic Myeloid Leukemia.
Journal: Biomolecules & therapeutics
Published: January 22, 2024
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.
Journal: Journal of translational medicine
Published: December 06, 2023
Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.
Journal: Cancer letters
Published: November 26, 2023
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.
Journal: American journal of hematology
Published: September 25, 2023
Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.
Journal: International journal of biological sciences
Published: May 30, 2023
Last Updated: 09/26/2026